RCT of Bibliotherapy for Social Anxiety Disorder as a Prelude to CBT in IAPT
Launched by SOLENT NHS TRUST · Dec 3, 2014
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
P A R T I C I P A N T S
Patients will be recruited within an Improving Access to Psychological Therapies (IAPT) service: 'Talking Change' (Portsmouth). Advertisement for the study will be distributed locally, through social media and via the 'Talking Change' Internet website.
It is generally accepted that social anxiety disorder is a chronic condition and significant change in the wait-list does not occur. Hence, because the study aims to explore predicators of treatment response, a priori power analyses determined that approximately 114 patients randomly assigned for twelve-weeks at a ra...
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • ≥ 18 years of age;
- • ≥ 19 points on the Social Phobia Inventory (SPIN; Connor, 2000);
- • Meets full Diagnostic and Statistical Manual of Mental Disorders (5th ed.;
- • DSM-5; American Psychiatric Association, 2013) criteria for social anxiety disorder;
- • Social anxiety is the primary disorder requiring treatment;
- • Sufficient reading and writing ability (cut-off to be decided);
- • English is first language;
- • Stable dose of antidepressant medication for at least two months.
- • Patients who do not meet the inclusion criteria will be offered alternative treatment within the service or referred elsewhere as required.
- Exclusion criteria:
- • If co-morbidity present, social anxiety disorder is not the primary problem;
- • Another disorder (e.g., depression) requires urgent treatment in it's own right;
- • Past or present history of psychosis, borderline personality disorder, or bipolar disorder;
- • Risk to themselves or others; Drug and alcohol misuse;
- • Previous high-intensity Cognitive-Behavioural Therapy (CBT) for social anxiety disorder;
- • On-going psychological therapy;
- • Engaging in another research trial;
- • Psychotropic medication.
- • Patients who meet the exclusion criteria will be offered alternative treatment within the service or referred elsewhere as required.
About Solent Nhs Trust
Solent NHS Trust is a leading healthcare organization based in the UK, dedicated to delivering high-quality community health services to diverse populations. With a focus on innovation and patient-centered care, the Trust plays a pivotal role in advancing clinical research and trials that aim to improve health outcomes. By fostering collaboration among healthcare professionals, researchers, and patients, Solent NHS Trust is committed to enhancing the evidence base for clinical practices and ensuring that cutting-edge treatments and interventions are accessible to those in need.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portsmouth, Hampshire, United Kingdom
Patients applied
Trial Officials
Miles D Wrightman, MSc
Principal Investigator
University of Oxford
Professor David M Clark, DPhil
Study Director
University of Oxford
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials